fda glp-1 compounding crackdown news october 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Compounded GLP-1s: Why doctors worry
Description
I'm sharing my personal journey accessing compounded GLP-1 medications like Tirzepatide through Mochi Health
Are there still blue oceans and growth opportunities for GLP-1
Evidence-based comparison of CagriSema (cagrilintide + semaglutide) and semaglutide alone, including REDEFINE trial data and FDA filing status.
Achieve sustainable weight loss with Semaglutide therapy at Novella in Charlotte, NC
A state-by-state look at how affordable GLP-1 drugs like Ozempic and Zepbound really are and where cost keeps patients from access.
GLP-1 Made Specifically for Weight Loss
